This is Archived Content

This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). To view the latest NIDA Notes visit

Cite this article

NIDA. (1996, December 1). The Basics of Brain Imaging. Retrieved from

press ctrl+c to copy
December 01, 1996
Robert Mathias

The major neuroimaging techniques used in drug abuse research are positron emission tomography (PET), single photon emission computed tomography (SPECT),and magnetic resonance imaging (MRI), along with electro-encephalography(EEG), an earlier technique for monitoring brain activity. Advances in all these techniques are enabling scientists to produce remarkably detailed computer-screen images of brain structures and to observe neurochemical changes that occur in the brain as it processes information or responds to various stimuli such as drugs of abuse or drug abuse treatment medications.

PET, SPECT, MRI, and EEG are noninvasive procedures that can measure biological activity through the skull and reveal the living human brain at work. Each technique has its own advantages and each provides different information about brain structure and function. For this reason, scientists increasingly are conducting studies that integrate two or more techniques. For example, merging a PET scan image that shows activity at brain molecular sites, or receptors, with a highly detailed MRI image of brain structure can produce a composite image that makes it possible to identify more precisely where in the brain the activity is occurring.

PET-Positron Emission Tomography

PET measures emissions from radioactively labeled chemicals that have been injected into the bloodstream and uses the data to produce two- or three-dimensional images of the distribution of the chemicals throughout the brain and .

PET studies involve use of a machine called a cyclotron to "label"specific drugs or analogues of natural compounds, such as glucose,with small amounts of radioactivity. The labeled compound, which is called a radiotracer, is then injected into the bloodstream, which carries it to the brain. Sensors in the PET scanner detect the radioactivity as the compound accumulates in different regions of the brain. A computer uses the data gathered by the sensors to construct multicolored two- or three-dimensional images that show where the compound acts in the brain.

Using different compounds, PET can show blood flow, oxygen and glucose metabolism,and drug concentrations in the tissues of the working brain. Blood flow and oxygen and glucose metabolism reflect the amount of brain activity indifferent regions and enable scientists to learn more about the physiology and neurochemistry of the working brain.

In drug abuse research, PET scans are being used to identify the brain sites where drugs and naturally occurring neurotransmitters act, to show how quickly drugs reach and activate a neural receptor, and to determine how long drugs occupy these receptors and how long they take to leave the brain. PET is also being used to show brain changes following chronic drug abuse, during withdrawal from drugs, and while the research volunteer is experiencing drug craving. In addition, PET can be used to assess the brain effects of pharmacological and behavioral therapies for drug abuse.

SPECT-Single Photon Emission Computed Tomography

Similar to PET, this imaging procedure also uses radioactive tracers and a scanner to record data that a computer uses to construct two- or three-dimensional images of active brain regions.

Generally, SPECT tracers are more limited than PET tracers in the kinds of brain activity they can monitor. SPECT tracers also deteriorate more slowly than many PET tracers, which means that SPECT studies require longer test and retest periods than PET studies do. However, because SPECT tracers are longer lasting, they do not require an onsite cyclotron to produce them. SPECT studies also require less technical and medical staff support thanPET studies do. While PET is more versatile than SPECT and produces more detailed images with a higher degree of resolution, particularly of deeper brain structures, SPECT is much less expensive than PET and can address many of the same drug abuse research questions that PET can.

MRI-Magnetic Resonance Imaging

MRI uses magnetic fields and radio waves to produce high-quality two- or three dimensional images of brain structures without injecting radioactive tracers.

In the procedure, a large cylindrical magnet creates a magnetic field around the research volunteer's head, and radio waves are sent through the magnetic field. Sensors read the signals and a computer uses the information to construct an image. Using MRI, scientists can image both surface and deep brain structures with a high degree of anatomical detail, and they can detect minute changes in these structures that occur over time.Within the last few years, scientists have developed techniques that enable them to use MRI to image the brain as it functions. Functional MRI (fMRI)relies on the magnetic properties of blood to enable scientists to see images of blood flow in the brain as it is occurring. Thus researchers can make "movies" of changes in brain activity as patients perform various tasks or are exposed to various stimuli.

An fMRI scan can produce images of brain activity as fast as every second,whereas PET usually takes 40 seconds or much longer to image brain activity.Thus, with fMRI, scientists can determine with greater precision when brain regions become active and how long they remain active. As a result, they can see whether brain activity occurs simultaneously or sequentially indifferent brain regions as a patient thinks, feels, or reacts to experimental conditions.

An fMRI scan can also produce high-quality images that can pinpoint exactly which areas of the brain are being activated. For example, fMRI can produce an image that distinguishes structures less than a millimeter apart, whereas the latest commercial PET scanners can resolve images of structures within4 millimeters of each other.

In summary, fMRI provides superior image clarity along with the ability to assess blood flow and brain function in seconds. To date, however, PET retains the significant advantage of being able to identify which brain receptors are being activated by neurotransmitters, abused drugs, and potential treatment compounds.


Electroencephalography uses electrodes placed on the scalp to detect and measure patterns of electrical activity emanating from the brain.

In recent years, EEG has undergone technological advances that have increased its ability to read brain activity data from the entire head simultaneously.

EEG can determine the relative strengths and positions of electrical activity in different brain regions. By tracking changes in this activity during such drug abuse-related phenomena as euphoria and craving, scientists can determine brain areas and patterns of activity that mark these phenomena.

The greatest advantage of EEG is speed-it can record complex patterns of neural activity occurring within fractions of a second after a stimulus has been administered. The biggest drawback to EEG is that it provides less spatial resolution than fMRI and PET do. As a result, researchers often combine EEG images of brain electrical activity with MRI scans to better pinpoint the location of the activity within the brain.


Aine, C.J. A conceptual overview and critique of functional neuro-imaging techniques in humans: I. MRI/fMRI and PET. Critical Reviews in Neurobiology9(2-3):229-309, 1995.